Clinical Trial Update: Evaluation of Hemostatic Agents in Partial Nephrectomy [NA]

View source ↗

Summary

A completed clinical trial evaluating hemostatic agents used during partial nephrectomy to assess bleeding control in localized renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Ankara University | Conditions: Partial Nephrectomy, Hemostatic Agents | NA | Status: COMPLETED